(Q39138386)

9 September 2017

title

The public health dimension of chronic kidney disease: what we have learnt over the past decade (English)

1 reference

chronic renal insufficiency

9 September 2017

0 references

1 reference

2

Josef Coresh

1 reference

9 September 2017

Jiun-Ruey Hu

1

1 reference

9 September 2017

language of work or name

English

0 references

publication date

16 February 2017

1 reference

Nephrology Dialysis Transplantation

9 September 2017

published in

1 reference

9 September 2017

volume

32

1 reference

9 September 2017

issue

suppl_2

1 reference

9 September 2017

page(s)

ii113-ii120

1 reference

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Cystatin C and the risk of death and cardiovascular events among elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Estimating glomerular filtration rate from serum creatinine and cystatin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Trends in Prevalence of Chronic Kidney Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Worldwide access to treatment for end-stage kidney disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Chronic kidney disease: global dimension and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Aristolochic acid nephropathy: a worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Chronic kidney disease of unknown aetiology in Sri Lanka: is cadmium a likely cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Multiple loci associated with indices of renal function and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Uromodulin levels associate with a common UMOD variant and risk for incident CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

APOL1 risk variants, race, and progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

A predictive model for progression of chronic kidney disease to kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Consent for research with biological samples: one-time general consent versus a gift model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Screening for proteinuria in US adults: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

Epidemiology, impact and preventive care of chronic kidney disease in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW416

21 January 2018

Identifiers

DOI

10.1093/NDT/GFW416

1 reference

9 September 2017

1 reference